Sprachauswahl

Forschung und Entwicklung

Klinische Studien

Die klinischen Studien sind in der Entwicklung von Arzneimitteln der zentrale Schritt. Hier finden Sie eine Darstellung aller laufenden klinischen Studien von Biotest.

Immunologie

Titel

Indikation

Status

 
Cytotect (Studie 963) CMV Prophylaxe in der Schwangerschaft Studie beendet

Prävention der Übertragung von humanem Cytomegalievirus (HCMV) von der Mutter auf den Fetus durch die Gabe von Virus spezifischem Hyperimmunglobulin bei schwangeren Frauen mit primärer HCMV Infektion

Link clinicaltrialsregister.eu
 
BT-063 (Studie 977) Systemischer Lupus Erythematodes Studie beendet

A prospective, open-label, mono-centre study to investigate safety, tolerability, pharmacokinetic and immunological properties of single IV doses of the humanised anti-IL-10 monoclonal antibody BT063

 
BT-063 (Studie 990) Systemischer Lupus Erythematodes Studie läuft

 

Hämatologie

Titel

Indikation

Status

 
Indatuximab Ravtansine* (Studie 989) Solide Tumore Studie läuft

An open-label, twostage Phase I/IIa dose escalation study of BT062 in metastatic triple receptor-negative breast cancer and in metastatic transitional cell carcinoma of the urinary bladder

Link clinicaltrialsregister.eu
 
Indatuximab Ravtansine (Studie 969) Multiples Myelom Studie beendet

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

 
Indatuximab Ravtansine (Studie 975) Multiples Myelom Studie beendet

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

 
Indatuximab Ravtansine (Studie 983) Multiples Myelom Studie läuft

BT062 in Combination With Lenalidomide/Dexamethasone in Patients With Multiple Myeloma

Link clinicaltrials.gov
 

Intensivmedizin

Titel

Indikation

Status

 
Fibrinogen (Studie 995) Erworbener Fibrinogenmangel Studie läuft

A randomized, active-controlled, multicenter, phase III study investigating efficacy and safety of intra-operative use of BT524 (human fibrinogen concentrate) in subjects undergoing major spine surgery (AdFIrst).

Link clinicaltrials.gov
 
Fibrinogen (Studie 984) Angeborener Fibrinogenmangel Studie läuft

A prospective, open-label, phase I/III study investigating pharmacokinetic properties of BT524 and efficacy and safety of BT524 in the treatment and prophylaxis of bleeding in patients with congenital fibrinogen deficiency.

Link clinicaltrials.gov
 
IgM Concentrate (Studie 970) Schwere ambulant erworbene Lungenentzündung Studie beendet

A prospective, randomised, placebo-controlled, and single-blind phase I study investigating safety, tolerability, and pharmacokinetic properties of IgM Concentrate BT086 in healthy subjects

 
Trimodulin (Studie 982) Schwere ambulant erworbene Lungenentzündung Studie beendet

A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group, Adaptive Group-sequential Phase II Study, to Determine the Efficacy and Safety of BT086 as an Adjunctive Treatment i Severe Community Acquired Pneumonia (sCAP)

Link clinicaltrials.gov